Home
NICE Guidance
Published Guidance

Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease

Technology appraisal guidance [TA111] Published: 22 November 2006

Guidance

This guidance has been updated and replaced by NICE technology appraisal 217.